Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz J Med Biol Res ; 56: e12659, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37075347

RESUMO

Dendritic cells (DCs) are antigen-presenting cells that drive the differentiation of T CD4+ cells into different profiles according to the nature of the antigen or immunomodulator. Propolis is a resinous product made by bees that has numerous pharmacological properties, including an immunomodulatory action. To assess whether propolis can modulate the activation of CD4+ T cells by stimulating DCs with heat-labile enterotoxin B subunit (EtxB) or lipopolysaccharide (LPS), we aimed to elucidate the mechanisms affected by propolis in the differential activation of T lymphocytes. Cell viability, lymphocyte proliferation, gene expression (GATA-3 and RORc), and cytokine production (interleukin (IL)-4 and IL-17A) were analyzed. Propolis, EtxB, and LPS induced a higher lymphoproliferation compared with the control. Propolis induced GATA-3 expression and, in combination with EtxB, maintained the baseline levels. Propolis alone or in combination with LPS inhibited RORc expression. EtxB alone and in combination with propolis increased IL-4 production. Propolis in combination with LPS prevented LPS-induced IL-17A production. These results opened perspectives for the study of biological events that may be favored by propolis by promoting Th2 activation or helping in the treatment of inflammatory conditions mediated by Th17 cells.


Assuntos
Toxinas Bacterianas , Proteínas de Escherichia coli , Própole , Toxinas Bacterianas/farmacologia , Lipopolissacarídeos/farmacologia , Própole/farmacologia , Interleucina-17 , Células Th17 , Proteínas de Escherichia coli/farmacologia , Células Dendríticas , Células Th2
2.
Braz. j. med. biol. res ; 56: e12659, 2023. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1430016

RESUMO

Dendritic cells (DCs) are antigen-presenting cells that drive the differentiation of T CD4+ cells into different profiles according to the nature of the antigen or immunomodulator. Propolis is a resinous product made by bees that has numerous pharmacological properties, including an immunomodulatory action. To assess whether propolis can modulate the activation of CD4+ T cells by stimulating DCs with heat-labile enterotoxin B subunit (EtxB) or lipopolysaccharide (LPS), we aimed to elucidate the mechanisms affected by propolis in the differential activation of T lymphocytes. Cell viability, lymphocyte proliferation, gene expression (GATA-3 and RORc), and cytokine production (interleukin (IL)-4 and IL-17A) were analyzed. Propolis, EtxB, and LPS induced a higher lymphoproliferation compared with the control. Propolis induced GATA-3 expression and, in combination with EtxB, maintained the baseline levels. Propolis alone or in combination with LPS inhibited RORc expression. EtxB alone and in combination with propolis increased IL-4 production. Propolis in combination with LPS prevented LPS-induced IL-17A production. These results opened perspectives for the study of biological events that may be favored by propolis by promoting Th2 activation or helping in the treatment of inflammatory conditions mediated by Th17 cells.

3.
Nat Prod Res ; 27(18): 1646-50, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23163304

RESUMO

A possible immunomodulatory/anti-inflammatory effect of Baccharis dracunculifolia (Bd) and its major compound--caffeic acid (Ca)--on cytokines production (IL-1ß, IL-6 and IL-10) by murine macrophages was investigated. Cells were incubated with Bd and Ca, and the inhibitory concentrations were tested before or after macrophages challenge with LPS. Bd and Ca stimulated IL-1ß and inhibited IL-6 and IL-10 production. In LPS-challenge protocols, Bd prevented LPS action either before or after LPS challenge, whereas Ca prevented LPS effects only after LPS addition. Bd modulatory action on cytokines production may be at least in part mediated by Ca, since it has been shown to inhibit the transcription factor NF-κB. Further studies are still needed to evaluate Bd efficacy in inflammatory diseases, in order to explore its antiinflammatory activity in vivo.


Assuntos
Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Baccharis/química , Fatores Imunológicos/química , Fatores Imunológicos/farmacologia , Folhas de Planta/química , Animais , Cromatografia Líquida de Alta Pressão , Interleucina-10/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Macrófagos Peritoneais/efeitos dos fármacos , Camundongos , NF-kappa B/metabolismo
4.
Phytother Res ; 27(9): 1277-81, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23074147

RESUMO

Osteosarcoma (OSA) is a primary bone neoplasm frequently diagnosed in dogs. The biology of OSA in pet dogs is identical to that of pediatric patients, and it has been considered an excellent model in vivo to study human OSA. Since the individual response to chemotherapy is unpredictable and considering that propolis is a natural product with several biological properties, this work evaluated the cytotoxic action of propolis on canine OSA cells. The primary cell culture of canine OSA was obtained from the tumor of a dog with OSA. Cell viability was assessed after incubation with propolis, 70% ethanol (propolis solvent), and carboplatin after 6, 24, 48, and 72 h. Cell viability was analyzed by the crystal violet method. Data showed that canine OSA cells were sensitive to propolis in a dose- and time-dependent manner and had a distinct morphology compared to control. Its solvent (70% ethanol) had no effect on cell viability, suggesting that the cytotoxic action was exclusively due to propolis. Our propolis sample exerted a cytotoxic effect on canine OSA cells, and its introduction as a possible therapeutic agent in vivo could be investigated, providing a new contribution to OSA treatment.


Assuntos
Antineoplásicos/farmacologia , Neoplasias Ósseas/patologia , Osteossarcoma/patologia , Própole/farmacologia , Animais , Brasil , Carboplatina/farmacologia , Sobrevivência Celular , Modelos Animais de Doenças , Cães , Células Tumorais Cultivadas
5.
Phytother Res ; 26(9): 1308-13, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22275284

RESUMO

Since propolis and phenolic compounds, such as cinnamic and coumaric acids, have several biological properties, their immunomodulatory effect on cytokine production (IL-1ß, IL-6 and IL-10) was investigated. Peritoneal macrophages from BALB/c mice were incubated with propolis, coumaric and cinnamic acids in different concentrations and the concentrations that inhibited cytokine production were tested before or after macrophage challenge with LPS, to evaluate a possible immunomodulatory action. Propolis and the acids stimulated IL-1ß production, while IL-6 production was significantly inhibited after incubation with propolis (5, 50 and 100 µg/well), coumaric and cinnamic acids (50 and 100 µg/well). In LPS-challenge protocols, inhibitory concentrations of cinnamic and coumaric acids after LPS incubation prevented efficiently its effects on IL-6 production, whereas propolis inhibited LPS effects both before and after its addition. Propolis, coumaric and cinnamic acids (50 and 100 µg/well) inhibited IL-10 production as well. Both acids showed a similar inhibitory activity on IL-10 production when added after LPS challenge, while propolis counteracted LPS action when added before and after LPS incubation. Propolis modulated the immune/inflammatory response, depending on the concentration. Its efficiency may occur due to the synergistic effect of its compounds, and cinnamic and coumaric acids may be involved in the action of propolis on cytokine production.


Assuntos
Interleucina-10/biossíntese , Interleucina-1beta/biossíntese , Interleucina-6/biossíntese , Macrófagos Peritoneais/efeitos dos fármacos , Própole/farmacologia , Animais , Células Cultivadas , Cinamatos/farmacologia , Ácidos Cumáricos/farmacologia , Macrófagos Peritoneais/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Própole/imunologia
6.
Nat Prod Res ; 26(4): 344-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21432720

RESUMO

Propolis is a honeybee product that has been used since ancient times because of its therapeutic effects. It can be used in the development of alternative therapies for the treatment of many diseases, and because propolis shows antibacterial action, this work was carried out in order to investigate a possible synergism between propolis and antibiotics acting on DNA (ciprofloxacin and norfloxacin) and on the metabolism (cotrimoxazole) against Salmonella typhi. Propolis samples collected in Brazil and Bulgaria were compared in these assays, and the synergism was investigated by using ½ and » of the minimal inhibitory concentration for propolis and antibiotics, evaluating the number of viable cells according to the incubation time. Brazilian and Bulgarian propolis showed antibacterial activity, but no synergistic effects with the three tested antibiotics were seen. Previous works by our laboratory have revealed that propolis has synergistic effects with antibiotics, acting on the bacterial wall and ribosome, but it does not seem to interact with antibiotics acting on DNA or folic acid, and only a bacteriostatic action was seen in these assay conditions.


Assuntos
Antibacterianos/farmacologia , Ácido Fólico/metabolismo , Própole/farmacologia , Salmonella typhi/efeitos dos fármacos , Brasil , Bulgária , Ciprofloxacina/farmacologia , DNA Bacteriano , Sinergismo Farmacológico , Testes de Sensibilidade Microbiana , Norfloxacino/farmacologia , Salmonella typhi/genética , Salmonella typhi/metabolismo , Combinação Trimetoprima e Sulfametoxazol/farmacologia
7.
Nat Prod Res ; 26(5): 430-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21660841

RESUMO

Salmonella enterica serovar Typhi is the causative agent of typhoid fever in humans, and the use of antibiotics is essential for controlling this infection; however, the excessive use of antibiotics may select resistant strains. Propolis is a honeybee product and its antimicrobial activity has been intensively investigated. Thus, the objective of this study was to investigate a possible synergism between propolis (collected in Brazil and Bulgaria) and antibiotics acting on the ribosome (chloramphenicol, tetracycline and neomycin) against Salmonella Typhi in vitro. The synergism was investigated by using ½ and » of the minimum inhibitory concentration for propolis and these antimicrobial agents, evaluating the number of viable cells according to the incubation time. Brazilian propolis showed a bacteriostatic action against S. Typhi, while Bulgarian propolis showed a bactericidal activity and a synergistic effect with the three antibiotics. Variations in the biological assays might be due to the differences in their chemical compositions. Based on the results, one may conclude that Bulgarian propolis showed an important antibacterial action, as well as a synergistic effect with antibiotics acting on the ribosome, which points out a possible therapeutic strategy evaluating the use of propolis preparations for the treatment of Salmonella Typhi infection.


Assuntos
Anti-Infecciosos/farmacologia , Própole/farmacologia , Ribossomos/efeitos dos fármacos , Salmonella typhi/efeitos dos fármacos , Sinergismo Farmacológico , Testes de Sensibilidade Microbiana
8.
Poult Sci ; 90(6): 1227-33, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21597063

RESUMO

Propolis is a honeybee product showing several biological properties that enhance the immune response, depending on the concentration and intake period. Because propolis possesses an immunomodulatory action on mammals, the objective of our study was to investigate the effects of propolis on the humoral immune response of laying hens by evaluating antibody production. Laying hens (ISA Brown) were divided into 5 groups with 7 birds each. Group 1 was a nonimmunized control, whereas birds in group 2 were immunized intravenously with SRBC, and those in groups 3, 4, and 5 were treated intraperitoneally with propolis (2, 10, and 50 mg/kg, respectively) on 3 consecutive days and then inoculated intravenously with SRBC. Hematological and serological analyses were carried out on d 0, 3, and 38. Natural and specific antibody levels were determined by hemagglutination with rabbit red blood cells and SRBC, respectively. Propolis-treated birds (50 mg/kg) showed a significant decline in heterophils and in the heterophil:lymphocyte ratio. After SRBC immunization, significant increases in levels of IgG were observed in groups 4 and 5. Furthermore, higher levels of natural antibodies were observed in propolis-treated laying hens. The administration of propolis to laying hens increased the production of IgG specific to SRBC and natural antibodies, and could be used to increase antigen-specific antibody responses to vaccines.


Assuntos
Galinhas/imunologia , Suplementos Nutricionais , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Própole/farmacologia , Animais , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/farmacologia , Eritrócitos/imunologia , Feminino , Imunoglobulina G/imunologia , Imunoglobulina M/imunologia , Ovinos
9.
J. Venom. Anim. Toxins incl. Trop. Dis. ; 17(2): 159-167, 2011. graf, tab
Artigo em Inglês | VETINDEX | ID: vti-4499

RESUMO

In the present study, Apis mellifera propolis and essential oils (EOs) obtained from aromatic plants were evaluated as alternative antimicrobials. We aimed to establish the antimicrobial activity of ethanolic extracts of propolis (EEP) from Apis mellifera and of EOs from Caryophyllus aromaticus, Zingiber officinale, Cinnamomum zeylanicum and Mentha piperita against 32 Staphylococcus aureus and Escherichia coli strains from human clinical specimens. The antimicrobials were diluted in agar and the minimal inhibitory concentrations (MIC) were found whereas MIC90 percent values were calculated. Time-kill curve assays using mixtures containing one quarter of MIC90 percent for EEP with all EOs as well cinnamon EO were performed. The cinnamon EO was found to be the most efficient, with MIC90 percent values of 1.22 and 0.96 mg x mL-1 respectively against S. aureus and E. coli, whereas MIC90 percent of EEP were 1.86 and 20.12 mg x mL-1 respectively against S. aureus and E. coli. The combinations of EEP with ginger and mint EOs, and cinnamon with ginger and clove EOs, showed synergistic effects. Consequently, further studies are necessary to confirm these activities in vivo and to evaluate the phytochemical characteristics of natural products.(AU)


Assuntos
Animais , Produtos Biológicos/farmacologia , 26016/uso terapêutico , Própole , Óleos
10.
J. venom. anim. toxins incl. trop. dis ; 17(2): 159-167, 2011. graf, tab
Artigo em Inglês | LILACS | ID: lil-587775

RESUMO

In the present study, Apis mellifera propolis and essential oils (EOs) obtained from aromatic plants were evaluated as alternative antimicrobials. We aimed to establish the antimicrobial activity of ethanolic extracts of propolis (EEP) from Apis mellifera and of EOs from Caryophyllus aromaticus, Zingiber officinale, Cinnamomum zeylanicum and Mentha piperita against 32 Staphylococcus aureus and Escherichia coli strains from human clinical specimens. The antimicrobials were diluted in agar and the minimal inhibitory concentrations (MIC) were found whereas MIC90 percent values were calculated. Time-kill curve assays using mixtures containing one quarter of MIC90 percent for EEP with all EOs as well cinnamon EO were performed. The cinnamon EO was found to be the most efficient, with MIC90 percent values of 1.22 and 0.96 mg x mL-1 respectively against S. aureus and E. coli, whereas MIC90 percent of EEP were 1.86 and 20.12 mg x mL-1 respectively against S. aureus and E. coli. The combinations of EEP with ginger and mint EOs, and cinnamon with ginger and clove EOs, showed synergistic effects. Consequently, further studies are necessary to confirm these activities in vivo and to evaluate the phytochemical characteristics of natural products.


Assuntos
Abelhas , Produtos Biológicos , Escherichia coli , Óleos Voláteis , Própole/antagonistas & inibidores , Staphylococcus aureus , Extratos Aromáticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA